| Income Statement | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-09-30 |
|---|---|---|---|---|
| Income (loss) from continuing operations before income taxes, noncontrolling interest | -431,100 | 414,000 | 83,400 | 861,620 |
| (provision) benefit for income taxes | -89,200 | 96,200 | 19,400 | 208,448 |
| Net income attributable to bio-rad | -341,900 | 317,800 | 64,000 | 653,172 |
| Net income per share basic attributable to bio-rad | -12.7 | 11.67 | 2.29 | 23.37 |
| Net income per share diluted attributable to bio-rad | -12.7 | 11.67 | 2.29 | 23.34 |
| Weighted average common shares - basic | 26,923,000 | 27,226,000 | 27,941,000 | 27,949,000 |
| Weighted average common shares - diluted | 26,923,000 | 27,228,000 | 27,955,000 | 27,985,000 |
BIO-RAD LABORATORIES, INC. (BIO)
BIO-RAD LABORATORIES, INC. (BIO)